Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Dec;116(12):2386-92.
doi: 10.1016/j.ophtha.2009.05.031. Epub 2009 Oct 7.

Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women

William G Christen  1 , Robert J Glynn, Emily Y Chew, Julie E Buring
Affiliations
Randomized Controlled Trial

Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women

William G Christen et al. Ophthalmology. 2009 Dec.

Abstract

Objective: To test whether alternate-day low-dose aspirin affects incidence of age-related macular degeneration (AMD) in a large-scale randomized trial of women.

Design: Randomized, double-masked, placebo-controlled trial.

Participants: Thirty-nine thousand eight hundred seventy-six healthy female health professionals aged 45 years or older.

Intervention: Participants were assigned randomly to receive either 100 mg aspirin on alternate days or placebo and were followed up for the presence of AMD for an average of 10 years.

Main outcome measures: Incident AMD responsible for a reduction in best-corrected visual acuity to 20/30 or worse based on self-report confirmed by medical record review.

Results: After 10 years of treatment and follow-up, there were 111 cases of AMD in the aspirin group and 134 cases in the placebo group (hazard ratio, 0.82; 95% confidence interval, 0.64-1.06).

Conclusions: In a large-scale randomized trial of female health professionals with 10 years of treatment and follow-up, low-dose aspirin had no large beneficial or harmful effect on risk of AMD.

PubMed Disclaimer

Comment in

References

    1. Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72. - PubMed
    1. Klein R, Wang Q, Klein BE, et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182–91. - PubMed
    1. Hogg RE, Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res. 2006;25:249–76. - PubMed
    1. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2002;109:1767–79. - PubMed
    1. Age-Related Eye Disease Study Research Group A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol. 2005;123:1570–4. - PMC - PubMed

Publication types

MeSH terms

Substances